Invention Grant
- Patent Title: Morpholine carboxamide prokineticin receptor antagonists
- Patent Title (中): 吗啉羧酰胺原动蛋白受体拮抗剂
-
Application No.: US12085978Application Date: 2006-12-04
-
Publication No.: US07855201B2Publication Date: 2010-12-21
- Inventor: Wayne J. Thompson , Jeffrey Y. Melamed
- Applicant: Wayne J. Thompson , Jeffrey Y. Melamed
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme. Corp.
- Current Assignee: Merck Sharp & Dohme. Corp.
- Current Assignee Address: US NJ Rahway
- Agent J. Eric Thies; Gerard M. Devlin
- International Application: PCT/US2006/046330 WO 20061204
- International Announcement: WO2007/067511 WO 20070614
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D413/14
Abstract:
The present invention is directed to morpholine carboxamide compounds which are antagonists of prokineticin receptors, in particular antagonists of prokineticin 2 receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which prokineticin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which prokineticin receptors are involved.
Public/Granted literature
- US20090306076A1 Morpholine Carboxamide Prokineticin Receptor Antagonists Public/Granted day:2009-12-10
Information query
IPC分类:
